Prognostic impact of discordance in hormone receptor status after the neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Kurihara, Toshiaki [1 ]
Ueno, Hanako [1 ]
Takemae, Masaru [1 ]
Nagayama, Aiko [1 ]
Takahashi, Maiko [1 ]
Hayashida, Tetsu [1 ]
Jinno, Hiromitsu [1 ]
Kitagawa, Yuko [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo 108, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P3-06-49
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-49
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CHANGES IN BIOMARKER STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
    Matsumoto, A.
    Takahashi, M.
    Hayashida, T.
    Hirose, S.
    Jinno, H.
    Kitagawa, Y.
    BREAST, 2013, 22 : S64 - S64
  • [42] The effect of neoadjuvant chemotherapy on hormone receptor status, HER2/neu and prolactin in breast cancer
    Pedrini, Jose Luiz
    Savaris, Ricardo Francalacci
    Schorr, Mario Casales
    Cambruzi, Eduardo
    Grudzinski, Melina
    Zettler, Claudio Galleano
    TUMORI JOURNAL, 2011, 97 (06): : 704 - 710
  • [43] Discordance in hormone receptor status in breast cancer during tumor progression.
    Karlsson, E.
    Lindstrom, L. S.
    Wilking, U.
    Skoog, L.
    Johansson, U.
    Bergh, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Discordance of estrogen and progesterone receptors after neoadjuvant chemotherapy in locally advanced breast cancer
    Gupta, Surabhi
    Anto, Alvin
    Singhal, Juhi
    Agarwal, Pooja
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S335 - S340
  • [45] Prognostic factors for survival after recurrent metastasized breast cancer by hormone receptor status
    Kwast, A. B. G.
    Voogd, A. C.
    Menke-Pluijmers, M. B. E.
    Linn, S.
    Kiemeney, L. A.
    Siesling, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S411 - S411
  • [46] A Call to Re-evaluate Receptor Status for Breast Cancer Patients after Neoadjuvant Chemotherapy
    Huang, Jin
    Huynh, Victoria
    Ahrendt, Gretchen M.
    Afghahi, Anosheh
    Sams, Sharon
    Tevis, Sarah
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S31 - S31
  • [47] Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study
    Chen, Yuhai
    Liu, Xiaoyan
    Yu, Keda
    Sun, Xiangyu
    Xu, Shouping
    Qiu, Pengfei
    Lv, Zhidong
    Zhang, Xinwen
    Guo, Ayao
    Xu, Yingying
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
  • [48] Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
    Tsai, Jacqueline
    Bertoni, Danielle
    Hernandez-Boussard, Tina
    Telli, Melinda L.
    Wapnir, Irene L.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (10) : 3310 - 3316
  • [49] Conversion to node-negative after neoadjuvant chemotherapy is a surrogate prognostic marker in patients with hormone receptor-positive breast cancer
    Takahashi, Y.
    Hayashi, N.
    Matsuda, N.
    Kajiura, Y.
    Yoshida, A.
    Yagata, H.
    Nakamura, S.
    Suzuki, K.
    Tsunoda, H.
    Yamauchi, H.
    CANCER RESEARCH, 2013, 73
  • [50] Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
    Jacqueline Tsai
    Danielle Bertoni
    Tina Hernandez-Boussard
    Melinda L. Telli
    Irene L. Wapnir
    Annals of Surgical Oncology, 2016, 23 : 3310 - 3316
12345